Quantcast

Latest Amides Stories

2014-01-18 23:02:37

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) January 18, 2014 The DrugNews prescription drug safety center has added new information to its legal news resource for patients who’ve taken the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding have grown in the past month*. The news comes as...

2014-01-17 23:23:26

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 17, 2014 The prescription medication safety advocates at DrugRisk.com have added new information for those who have taken the blood thinner Pradaxa. The FDA recently ordered a new study of patient data in order to determine the safety of the drug*. DrugRisk is a free consumer resource designed to improve...

2014-01-16 23:01:30

The Firm is investigating Pradaxa lawsuits on behalf of individuals treated with the blood thinner who allegedly suffered life-threatening episodes of internal bleeding due to its use. New York, New York (PRWEB) January 16, 2014 Bernstein Liebhard LLP continues to monitor developments involving the thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) filed on behalf of individuals who allegedly suffered life-threatening episodes of internal bleeding due to their use of the...

2014-01-13 08:30:13

Topline Data Will Be Presented at Biotech Showcase HEIDELBERG, Germany, Jan. 13, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today the successful completion of its phase II proof-of-concept trial with APG101 in patients with recurrent glioblastoma. All endpoints of the randomized controlled trial that compared the efficacy and safety of a combination therapy of APG101 and radiotherapy versus radiotherapy alone were achieved or...

2014-01-09 23:25:52

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) January 09, 2014 The DrugNews prescription drug safety center has added new information for patients who’ve taken the blood thinner Pradaxa. The FDA has ordered a new review of user data in order to assess the safety of the drug*. The news comes as court records revealed the number of lawsuits alleging the...

2014-01-06 23:02:11

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who suffered serious occurrences of internal bleeding, allegedly due to their use of the blood thinner. New York, New York (PRWEB) January 06, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in courts around the country, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) is planning a large scale assessment of Pradaxa bleeding rates. In a posting on an...

2013-12-20 23:23:06

National network of attorneys will continue to accept inquiries through New Year's Day about legal options to seek compensation over allegations that Pradaxa may cause bleeding problems. San Diego, CA (PRWEB) December 20, 2013 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople announced today that its national network of attorneys will be available over the upcoming holiday season to consumers inquiring about litigation involving allegations that...

2013-12-10 23:19:52

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being...

2013-12-10 23:19:45

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.